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Abstract: Adequate nutrition of very preterm infants comprises fortification of human milk (HM),
which helps to improve their nutrition and health. Standard HM fortification involves a fixed dose
of a multi-nutrient HM fortifier, regardless of the composition of HM. This fortification method
requires regular measurements of HM composition and has been suggested to be a more accurate
fortification method. This observational study protocol is designed to assess whether the target
HM fortification method (contemporary cohort) improves the energy and macronutrient intakes
and the quality of growth of very preterm infants, compared with the previously used standard
HM fortification (historical cohorts). In the contemporary cohort, a HM multi-nutrient fortifier and
modular supplements of protein and fat are used for HM fortification, and the enteral nutrition
recommendations of the European Society for Paediatric Gastroenterology Hepatology and Nutrition
for preterm infants will be considered. For both cohorts, the composition of HM is assessed using
the Miris Human Milk analyzer (Uppsala, Sweden). The quality of growth will be assessed by
in-hospital weight, length, and head circumference growth velocities and a single measurement
of adiposity (fat mass percentage and fat mass index) performed just after discharge, using the air
displacement plethysmography method (Pea Pod, Cosmed, Italy). ClinicalTrials.gov registration
number: NCT04400396.
Keywords: body composition; growth; human milk fortification; preterm infants; standard fortifica-
tion; target fortification
1. Introduction
1.1. Biological Advantages of Human Milk
Human milk (HM) is the first choice for feeding preterm infants [1], as it is the better
option that compensates for the immature immune [2,3], vascular [4], and neurological [5]
systems. In very and extremely preterm infants, HM has beneficial effects on the neurode-
velopmental outcome [6] and preventive effects on morbidities, including retinopathy of
prematurity [7], bronchopulmonary dysplasia [8], necrotizing enterocolitis [7,9], and late
sepsis [9].
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From a nutritional point of view, HM does not fulfill the needs of growing preterm
infants, resulting in accumulated nutrient deficits, which may lead to extrauterine growth
restriction and poor neurodevelopmental outcomes [10,11]. This is particularly true for
protein deficits [12]. Early postnatal growth restriction, in turn, predisposes individuals
to late metabolic diseases [11]. To prevent nutritional insufficiencies related to HM while
taking advantage of its biological properties, HM multi-nutrient fortifiers are used for
preterm infants [13–15].
1.2. Methods for Fortification of Human Milk
Human milk is fortified using the standard method, which consists of the addition of a
fixed dose of a HM multi-nutrient fortifier, according to the manufacturer’s instructions [14].
This method does not take into account the great variability of the nutritional composition
of HM [13–16] and so does not avoid the risks associated with energy–protein malnutrition,
poor neurodevelopmental outcome, and metabolic bone disease [17–19]. In an attempt to
overcome this problem, alternative individualized HM fortification methods have been
proposed, particularly target fortification [15].
The target fortification method is based on the regular measurements of the energy and
macronutrient contents of HM, in order to customize the target energy and macronutrients
to each infant [20]. In addition to the multi-nutrient fortifier, modular protein, carbohydrate,
and fat supplements may be added to HM to achieve the desirable nutrient targets for
preterm infants [15,21,22].
1.3. Questions to Be Answered
Many authors [21–24] consider the target HM fortification to be a more accurate
method to achieve adequate nutrition in preterm infants according to energy and protein
intakes recommended by the European Society for Paediatric Gastroenterology Hepatol-
ogy and Nutrition (ESPGHAN) [25]. However, this opinion is not unanimous, as other
authors found that the target HM fortification method, as compared to the standard HM
fortification, did not meet the recommended protein intake [26] or result in better growth
outcomes [27]. The target fortification method has also been described as inconvenient, as
a result of requiring a HM analyzer and being time-consuming and labor-intensive [27].
In order to comply with the ESPGHAN enteral nutrition recommendations for preterm
infants in clinical practice [25], more studies which take into account the osmolality of
feeds, feeding tolerance, and risk of necrotizing enterocolitis are needed [27], in order
to determine the safe maximum concentrations of multi-nutrient fortifiers and modular
protein supplements in the prescribed fluid intakes.
The current literature indicates that extremely and very preterm infants at term-
equivalent age have a lower fat-free mass (FFM) and a greater fat mass percentage (FM%),
compared with term-equivalent-age infants [28,29]. Reference values for body composi-
tion have been described for preterm infants [30,31], but the optimal body composition
evolution in those infants remains to be determined. This lack of knowledge relates not
only to the difficulty in defining the optimal nutrition intervention in preterm infants, a
major factor determining body composition, but also to the current unavailability of a
non-invasive, accurate, and easy to perform method for measuring body composition in
fragile preterm infants under intensive care, including soon after birth [32,33].
1.4. A Contribution to Answer Some Unsolved Questions
In a cohort study of very preterm infants fed standard fortified HM, we previously
evaluated the association between energy and macronutrient intakes and both weight gain
velocity and body composition [34,35]. We concluded that the actual energy, protein, and
fat intakes based on measured HM composition were significantly lower than the assumed
intakes based on estimates of HM composition [34]. This nutritional strategy is associ-
ated with a suboptimal weight gain velocity and low adiposity [35]. From this evidence,
following the ESPGHAN enteral nutrition recommendations for preterm infants [25], a
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nutritional strategy towards HM fortification based on measured HM composition was
recently introduced in our unit. It is considered important to assess the effects of the newly
implemented nutritional strategy.
1.5. Objective
The aim of this study protocol is to assess whether the newly implemented target HM
fortification method, based on measured HM composition, improves both the energy and
macronutrient intakes and the quality of growth in very preterm infants, compared with
standard HM fortification.
1.6. Hypotheses
In very preterm infants, the customized HM fortification based on measured HM
composition is expected to improve energy and macronutrient intakes, compared with the
standard HM fortification. As a consequence of better nutrition provided by the target
HM fortification, the quality of growth will improve, reflected by faster growth rates while
achieving an adiposity at term-equivalent age similar to that of infants born at term.
2. Methods
2.1. Study Design
This single-center, observational mixed-cohort, effectiveness study in very preterm
infants (<33 weeks of gestation) will compare the energy and macronutrient intakes and
the growth and body composition between infants fed either target fortified HM, based
on measured HM composition (the contemporary cohort), or standard fortified HM (the
historical cohort).
2.2. Primary Outcome
We hypothesize that the HM fortification method based on measured HM composition
will result in higher energy and macronutrient intakes and faster weight gain velocity than
previously observed [35]. Weight gain velocity was chosen as the primary outcome to
estimate the sample size because it is considered an important measure of preterm infants’
health [10,36].
2.3. Secondary Outcomes
In addition, we hypothesize that in infants fed target fortified HM, adequate linear
and head growth velocities will be achieved [37,38], and adiposity at term-equivalent age
will be more similar to that of term-equivalent-age infants [28,29].
2.4. Setting, Participants, Study Periods, and Variables
The study will be conducted at the Centro Hospitalar Universitário de Lisboa Central,
in the Neonatology Unit and Human Milk Bank at Maternidade Dr. Alfredo da Costa, and
the Nutrition Laboratory at Hospital Dona Estefânia.
Recruitment for the contemporary cohort of infants fed target fortified HM was estimated
to start in February 2020, with a scheduled recruitment period of 16 months. We planned to
compare it with a historical cohort fed standard fortified HM in 2014–2015 [34,35], as stated
in the ClinicalTrials.gov NCT04400396 registry. However, there was a shortage in modular
protein supplement from February to July 2020, precluding the adoption of the new nutritional
protocol using the target HM fortification. In this context, the standard fortified HM arm will
include infants from two cohorts: the historical study period (1 February 2014 to 28 February
2015) [33,34] plus the contemporary period from 1 February to 13 July 2020, during which the
standard HM fortification was used.
The recruitment for the second contemporary cohort, including infants fed target
fortified HM based on measured HM composition, effectively started on 14 July 2020
(Table 1).
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Table 1. Study periods for the standard fortification and the target fortification arms.
Standard Fortification Arm Target Fortification Arm
– Historical study period: February 2014 to
February 2025
– 1st contemporary period: 1 February to
13 July 2020
2nd contemporary period: started on
14 July 2020
The eligibility criteria are those followed by the historical cohort study [34,35], i.e.,
consecutive cases of newborns delivered <33 weeks of gestation, admitted to the NICU of
Maternidade Dr. Alfredo da Costa (inborns and outborns), singletons or twins (=2), and
exclusively HM-fed or predominantly (≥87.5% volume per day) HM-fed were eligible.
Infants with a diagnosis of innate error of metabolism, those fed for two or more consecutive
days with formula ≥12.5% of daily volume intake, and those transferred to other hospitals,
deceased, or unavailable for body composition analysis after discharge will be excluded
(Figure 1).
Figure 1. Flow diagram including the eligibility, recruitment, and drop-out criteria, used in both
study arms: standard and target human milk fortification.
The study sample size was calculated based on the results obtained by Macedo et al. [35]
with the present historical cohort (mean 10.1, SD 3.8 g/Kg/d) and those obtained by McLeod
et al. [27] on a similar sample of very preterm infants fed a target HM fortification (mean 12.1,
SD 1.6 g/Kg/d). Therefore, the sample was estimated to detect a difference of 2 g/kg/day in
weight gain velocity, with a significance level of 0.05 and 80% power; thus, we estimated a
required sample of 68 infants: 34 infants in each cohort.
2.5. Nutrition Protocol
Infants will be managed according to the NICU nutrition protocol, taking into account
international and national guidelines for parenteral and enteral nutrition [25,39–43]. Par-
enteral nutrition is initiated within the first 2 postnatal hours and early trophic feeding
within the first 2 to 4 postnatal days using, preferentially, their mother’s own milk, and
when this is insufficient, using donor’s milk. Enteral nutrition is increased as the parenteral
nutrition is reduced. Nutritional schedule is as prescribed at the discretion of the attending
physician. A powdered multi-component HM fortifier (Aptamil FMS; Danone GmbH,
Friedrichsdorf, Germany), containing total energy 3.47 Kcal, protein 0.25 g, and carbohy-
drates 0.62 g per g of powder, will be started at a dose of 4.4 g/100 mL HM when the HM
intake is at least 80 mL/kg/day.
For the fortification method based on measured HM, mothers’ own milk will be ana-
lyzed once a week and donor’s milk will be analyzed after the pasteurization. According to
the measured HM composition, powdered modular protein (Aptamil Protein Supplement;
Danone GmbH, Friedrichsdorf, Germany), containing total energy 3.38 Kcal and protein
0.821 g per g of powder, and medium-chain triglycerides (MCT OIL; Danone, GmbH,
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Friedrichsdorf, Germany), containing total energy 9.0 Kcal and 1.0 g per 1 mL, will be
added to fortified HM to reach the target energy and protein daily intakes of total energy
110–135 Kcal/Kg and protein 3.5–4.0 g/Kg [25].
2.6. Collected Variables
2.6.1. Retrieved Data
The recorded demographic variables include gestational age, sex, singleton or twin,
birth weight, small-, appropriate-, or large-for-gestational age (<3rd percentile, ≥3rd per-
centile and ≤97th percentile, >97th percentile, respectively) [43], severity index (SNAPPE
II) [44], use of prenatal corticosteroids, diagnosis of late sepsis [45], necrotizing entero-
colitis (grade ≥ 3) [46], intraperiventricular hemorrhage (grade ≥ 3) [47], multiquistic
periventricular leukomalacia [48], and chronic lung disease [49].
2.6.2. Measurements
Analysis of HM composition. The HM will be analyzed using the Miris human milk
analyzer (Miris AB, Uppsala, Sweden) [50]. To minimize daily variability in breast milk
composition, mothers have been asked to add milk collected in 24 h to the same container.
The composition is expressed in densities: Kcal/dL of energy and g/dL of fat, raw and
true protein, carbohydrates, and ashes.
Assessment of nutrient intake. Daily intakes of energy (Kcal/kg), protein (g/kg),
and fat (g/kg), and protein/energy ratio (P/E), provided by administered HM (mL/kg),
non-supplemented or supplemented with multi-component HM fortifier and modular
protein and fat supplements will be calculated. An Excel program designed to facilitate
the calculations of the amount of modular protein and fat supplements to be added to
fortified HM was developed and registered (Nona R, Cardoso M, Portuguese Directorate
of Intellectual Property Services, IGAC-DSPI, no 480/2020, 26 February 2020).
Assessment of growth and body composition. During the hospital stay, the body
weight is routinely measured by the attending nurses, using scales incorporated in in-
cubators or external automatic scales. Weight gain velocity (g/kg/day) is calculated using
an exponential model [51]. The same observer (MMC) measures the length and head
circumference weekly, according to recommended methods [52,53], to calculate linear and
head growth velocities (cm/week). At term, postmenstrual age (around 40 weeks), the fat
mass (FM), FFM, %FM, percentage of FFM (%FFM), and FM index (FMI) are assessed using
displacement plethysmography (Pea Pod, Cosmed, Italy), as previously described [35].
Both %FM and FMI will be used as indicators of adiposity [35].
2.7. Statistical Analysis
The collected data will be introduced into a Microsoft Excel database (Microsoft Cor-
poration, 2018. Microsoft Excel, available at: https://office.microsoft.com/excel). The
Epidemiology and Statistics Office of the Research Center of Centro Hospitalar Univer-
sitário Lisboa Central will perform the statistical analysis. To consider the autocorrelation
structure due to the longitudinal nature of the study, generalized additive mixed-effect
regression models will be used to identify the variables that explain the variability of each
continuous outcome variable. Independent variables will be considered throughout the
univariable analysis, and all variables with p < 0.25 will be selected for the multivariable
models. A level of significance of α = 0.05 will be used, although p-values greater than
0.05 and lower than 0.1 (weak evidence of difference/association) will eventually be con-
sidered. Data will be analyzed using R (R: A Language and Environment for Statistical
Computing, R Core Team, R Foundation for Statistical Computing, Vienna, Austria, 2019,
http://www.R-project.org.).
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2.8. Ethical Issues and Study Registry
The present study was approved by the institutional ethics committee (Nr 558/2018).
The recruitment of participants requires the informed written consent obtained from the
mothers. The study is registered at www.clinicaltrials.gov ID: NCT04400396.
3. Discussion
3.1. Strengths
The fortification of HM based on its composition is guided by direct measurements,
using a validated method [54], instead of relying on estimates of HM composition reported
in systematic review data [55]. In addition, the amounts of modular protein and fat
supplements added to the fortified HM will be accurately calculated using an informatics
tool that has been specifically developed.
Anthropometric changes will be assessed by weight, length, and head circumference
growth rates, since they are more sensitive than examining the anthropometric parameters
plotted on growth curves [37,38]. The weight gain velocity will be calculated by the
exponential method [51], which is recommended in clinical and research settings and has
been proven to provide similar results as the previously described Average2pt method [56].
The quality of growth relies on body composition assessed by air displacement plethys-
mography, an accurate two-compartment method validated in preterm infants [57,58],
which is non-invasive, rapid to perform, and not affected by movements [33]. In addition
to the %FM, adiposity will be assessed by the FMI because it is considered to be a more
reliable indicator of adiposity [59], including in preterm infants [60].
3.2. Limitations
A randomized controlled longitudinal trial comparing methods of HM fortification
would be the ideal study design to assess which method of HM fortification better optimizes
energy and nutrient intakes and the quality of growth in very preterm infants. However,
an interventional design has ethical implications in assigning infants to the standard HM
fortification group, as an HM analyzer is available and the target HM fortification method
is considered by most authors [21–24] to be the best practice in terms of complying with
the high energy and protein intakes recommended by the ESPGHAN [25]. In this context,
we chose an observational study design, comparing two nutritional practices sequentially
adopted in our unit, i.e., the previously used standard HM fortification and the newly
adopted HM fortification based on measured HM composition.
As an observational study, the prescription of the nutrition support is at discretion of
the attending physicians, and we expect that they will lean towards the newly adopted
target HM fortification method. Even without reaching the target energy and protein
intakes recommended by the ESPGHAN [25], we expect that a HM fortification based
on measured HM composition will provide better quality of growth than the standard
HM fortification.
The ideal fortification method would be the target fortification guided by daily mea-
surements of HM composition; however, this is not feasible in our setting since it would
be excessively time-consuming, expensive, and labor-intensive [27]. Rochow et al. [61]
assessed a cost-effective frequency for the measurement of HM composition using the
target fortification method and found that measurements twice a week offer an acceptable
cost benefit to enhance macronutrient intake in extremely preterm infants. We will use an
alternative schedule proposed by Parat el al. [62], based on a weekly analysis, which seems
to be sufficient to achieve that purpose in very preterm infants.
To assess body composition, we will use a two-compartment model that does not
provide regional body composition. The ideal assessment would be longitudinal regular
measurements from birth, assessed through a validated method providing whole and regional
body composition, and the results would be compared with normative values obtained
from “healthy” preterm infants. These standards have not been constructed yet and a non-
invasive, accurate method assessing whole and regional body composition, including in
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fragile ventilated infants, from the first postnatal days, is still not available [32,33]. In addition,
a single measurement is only scheduled after discharge, as the equipment is located in the
pediatric hospital of the hospital center, not in the maternity ward where the neonatal unit
is located.
A cost effectiveness analysis comparing both HM fortification strategies and the
achievement of the growth targets is not planned.
4. Conclusions
This observational study was conceived to determine, in an effectiveness setting,
the best nutrition intervention in very preterm infants, following the ESPGHAN enteral
nutrition recommendations [25].
We expect to disclose whether a customized target HM fortification based on measured
HM composition improves both the energy and macronutrient intakes, compared with the
standard HM fortification, in very preterm infants. If a better energy and macronutrient
intake is achieved, we expect to observe whether the improved nutrient intake has an effect
on the quality of growth.
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